Stay updated with breaking news from Clinical Modification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This cohort study uses data from the US Food and Drug Administration Sentinel System to measure the 90-day risk of arterial thromboembolism and venous thromboem
Dr. James V. Anderson highlights the dental code changes that are set to go into effect on January 1, 2023.
Background Biliary atresia (BA) is a rare but severe cause of obliterative cholangiopathy in neonates. Its incidence differs worldwide varying from 5/100,000 to 32/100,000 live births. The highest incidence is seen in Asia and the Pacific region. Diagnosing this disease is difficult in its early stages; thus, screening is necessary to avoid serious complications that can be minimized with early intervention during the first few months of life. Currently, although there are no medical treatments for BA, once the diagnosis is confirmed, the Kasai procedure may be a treatment option. The earlier ...
/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the...
In a new study, researchers assessed the incidence of post-COVID-19 symptoms and conditions among children and adolescents.